3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
91
Carcinoma, Non-Small-Cell Lung
53
Lung Neoplasms
22
Hodgkin Disease
15
Recurrence
11
Lymphoma
10
Neoplasm Metastasis
9
Prostatic Neoplasms
7
Triple Negative Breast Neoplasms
6
Neoplasms
6
Sarcoma
4
Rhabdomyosarcoma
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large B-Cell, Diffuse
4
Adenocarcinoma of Lung
4
Multiple Myeloma
3
Mesothelioma, Malignant
3
Mesothelioma
3
Breast Neoplasms, Male
3
Uterine Cervical Neoplasms
2
Ovarian Neoplasms
2
Neuroblastoma
2
Melanoma
2
Lymphoma, Large-Cell, Anaplastic
2
HER2-negative Breast Cancer
2
Fallopian Tube Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Colonic Neoplasms
2
Brain Neoplasms
2
Advanced Breast Cancer
2
Interventions
Carboplatin
4
Trastuzumab
3
Cyclophosphamide
3
Paclitaxel
2
Letrozole
2
Fulvestrant
2
Docetaxel
2
repotrectinib
1
proto-oncogene protein c-fes-fps
1
palbociclib
1
neratinib
1
entrectinib
1
Vorinostat
1
Vinorelbine
1
Thiotepa
1
Taxes
1
Tamoxifen
1
Sugars
1
Radiotherapy
1
Positron Emission Tomography Computed Tomography
1
Neoadjuvant Therapy
1
Naltrexone
1
Melphalan
1
Mastectomy, Segmental
1
Magnetic Resonance Spectroscopy
1
Liquid Biopsy
1
High-Energy Shock Waves
1
Goserelin
1
Fluorine-18
1
Epirubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Lobular
×
Vinorelbine
×
Clear all
NCT01641406
2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2
Unknown
60 enrolled